Neoadjuvant Chemotherapy in Combination with Toripalimab Clinical Trials

3 actively recruiting trials

Pipeline

Phase 2: 2Phase 3: 1

Top Sponsors

First Affiliated Hospital of Zhejiang University3

Indications

Breast Cancer3
Cancer3
HR+/HER2- Breast Cancer2
HR Positive/HER2 Low Breast Cancer1

Other3 trials

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)

Phase 2

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)

Phase 3

Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.